Tools

LEADER 03515nam a2200565 i 4500

001 on1415804794;

003 OCoLC;

005 20240122153641.0;

006 m o d f ;

007 cr |||||||||||;

008 231221s2023 dcua ob f000 0 eng c;

024 8 a| 48-911q| (GPO jacket number);

035 a| (Sirsi) o1415804794;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1043-C (online);

086 0 a| Y 4.L 11/4:S.HRG.117-400;

245 13 a| An update on the ongoing federal response to COVID-19 :b| current status and future planning : hearing before the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining an update on the ongoing federal response to COVID-19, focusing on current status and future planning, June 16, 2022.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (iii, 104 pages) :b| color illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg. ;v| 117-400;

500 a| Associated bill citation(s): S. 2173.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| Access ID (govinfo): CHRG-117shrg48911.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Walensky, Rochelle, M.D., M.P.H., Director, United States Centers for Disease Control and Prevention, Atlanta, GA; Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Califf, Robert, M.D., Commissioner, United States Food and Drug Administration, Silver Spring, MD; O'Connell, Dawn, Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.;

518 a| Date of hearing: 2022-06-16.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed Dec. 20, 2023).;

650 0 a| COVID-19 (Disease)z| United States.=| ^A1407776;

650 0 a| Public health administrationz| United States.=| ^A1150;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.t| Update on the ongoing federal response to COVID-19w| (OCoLC)1415804570;

856 40 u| https://purl.fdlp.gov/GPO/gpo2210717| 0;

922 a| BIBCONEWb| 20231221;

922 a| PUBPOLTERMSb| 20231221;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6296667;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6296667-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 1/19/2024x| EDOCUMENTz| JERESOURCE;

An update on the ongoing federal response to COVID-19 : current status and future planning : hearing before the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining an update on the ongoing federal response to COVID-19, focusing on current status and future planning, June 16, 2022.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (iii, 104 pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo221071
Subjects	COVID-19 (Disease)--United States. COVID-19 (Disease)--Transmission. --United States. --Prevention. Emergency management--Finance. --Law and legislation. --United States. Public health administration--United States.

Series	S. hrg. ; 117-400 United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 117-400. ^A500722
General note	Associated bill citation(s): S. 2173.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	Access ID (govinfo): CHRG-117shrg48911.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Walensky, Rochelle, M.D., M.P.H., Director, United States Centers for Disease Control and Prevention, Atlanta, GA; Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Califf, Robert, M.D., Commissioner, United States Food and Drug Administration, Silver Spring, MD; O'Connell, Dawn, Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.
Date/time/place of a event note	Date of hearing: 2022-06-16.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed Dec. 20, 2023).
Issued in other form	Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Update on the ongoing federal response to COVID-19
Genre/form	Legislative hearings.
Standard identifier#	48-911 (GPO jacket number)
GPO item number	1043-C (online)
Govt. docs number	Y 4.L 11/4:S.HRG.117-400

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability